基于18F-FDG PET/CT的影像组学列线图用于识别儿童神经母细胞瘤无事件生存期
回顾性纳入126例儿童神经母细胞瘤患者,提取肿瘤及骨髓影像组学特征构建风险评分,联合国际神经母细胞瘤风险组分期建立无创联合模型,其预测无事件生存期的C-index在训练集和验证集分别为0.810和0.783,优于临床模型和常规PET模型。
要点
- 基于18F-FDG PET/CT的影像组学风险评分可对儿童神经母细胞瘤无事件生存期进行风险分层,低危与高危组间差异有统计学意义(P<.05)。
- 联合影像组学风险评分与INRG分期的无创联合模型预测效能最佳,训练集C-index 0.810、验证集0.783。
- 校准曲线和决策曲线分析提示无创联合模型具有良好一致性和临床实用性。
核心结论
- 基于18F-FDG PET/CT的神经母细胞瘤影像组学可可靠评估无事件生存期,无创联合模型效能优于临床模型和常规PET模型。
研究设计与样本
- 回顾性纳入126例神经母细胞瘤患者,按7:3比例随机分为训练集和验证集。
- 提取肿瘤及骨髓影像组学特征构建影像组学风险评分(RRS),采用Kaplan-Meier法评估RRS对无事件生存期的风险分层效能。
- 采用单因素和多因素Cox回归分析确定独立临床危险因素并构建临床模型。
- 基于常规PET参数构建常规PET模型;无创联合模型整合RRS与无创独立临床危险因素。
- 采用C-index、校准曲线和决策曲线分析(DCA)评估模型效能。
诊断标准与关键数值
- 共筛选15个影像组学特征构建RRS。
- 按RRS值定义的低危组与高危组之间无事件生存期差异有统计学意义(P<.05)。
- 无创联合模型(RRS联合国际神经母细胞瘤风险组分期)预测无事件生存期最佳,训练集C-index为0.810、验证集为0.783。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To investigate whether the 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) radiomics features that combine tumor and bone marrow can more accurately identify event-free survival (EFS) in pediatric neuroblastoma.
MATERIALS AND METHODS: A total of 126 patients with neuroblastoma were retrospectively included and randomly divided into the training and validation cohorts (7:3 ratio). Radiomics features were extracted to develop a tumor- and bone marrow-based radiomics risk score (RRS). The Kaplan-Meier method was used to evaluate the effectiveness of RRS in EFS risk stratification. Univariate and multivariate Cox regression analyses were used to determine independent clinical risk factors and construct the clinical models. The conventional PET model was constructed based on conventional PET parameters, and the noninvasive combined model integrated the RRS and the noninvasive independent clinical risk factors. The performance of the models was evaluated using C-index, calibration curves, and decision curve analysis (DCA).
RESULTS: A total of 15 radiomics features were selected to build the RRS. According to Kaplan-Meier analysis, there was a significant difference in EFS between the low-risk and high-risk groups as defined by the value of RRS (P < .05). The noninvasive combined model combining RRS and the International Neuroblastoma Risk Group stage achieved the best prognostic prediction of EFS, with a C-index of 0.810 and 0.783 in the training and validation cohorts, respectively. The calibration curves and DCA indicated that the noninvasive combined model had good consistency and clinical utility.
CONCLUSION: The 18F-FDG PET/CT-based radiomics of neuroblastoma allows a reliable evaluation of EFS. The performance of the noninvasive combined model was superior to the clinical and conventional PET models.
引用
- Feng, Zhang, Lu, et al. An Optimal Radiomics Nomogram Based on 18F-FDG PET/CT for Identifying Event-Free Survival in Pediatric Neuroblastoma. Acad Radiol. 2023. PMID: 37393177. doi:10.1016/j.acra.2023.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。